BIS(THIAZOL-5-YLMETHYL)-4,15-DIHYDROXY-10-ISOPROPYL-8,11-DIOXO-3,6,13,16-TETRABENZYL-2,7,9,12,17-PENTAAZAOCTADECANEDIOATE, (3S,4S,6S,10S,13S,15S,16S)-
UNII I8743EEB07
Substance Identification & Data
This profile provides standardized clinical and technical data for Bis(thiazol-5-ylmethyl)-4,15-dihydroxy-10-isopropyl-8,11-dioxo-3,6,13,16-tetrabenzyl-2,7,9,12,17-pentaazaoctadecanedioate, (3s,4s,6s,10s,13s,15s,16s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) I8743EEB07.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C52H61N7O8S2 UFFLDXFQXNYZLF-BHRSBNONSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Bis(thiazol-5-ylmethyl)-4,15-dihydroxy-10-isopropyl-8,11-dioxo-3,6,13,16-tetrabenzyl-2,7,9,12,17-pentaazaoctadecanedioate, (3s,4s,6s,10s,13s,15s,16s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.